InspireMD announces availability of new delivery system for MGuard stent

InspireMD Ltd. is announcing today the availability of a new and improved delivery system for its MGuard(TM) coronary stent system. The new delivery system, which has already been introduced in selected regions around the world, will now make its launch in South America during SOLACI 2010, taking place at the Hilton Hotel in Buenos Aires, Argentina, August 11th-13th.

The new delivery system offers a state-of-the-art design and superior deliverability. "We are very pleased with the flexibility and performance of the new delivery system. In our testing we have experienced a 15% improvement in crossing profile and 45% improvement in pushability resistance. These improvements will directly benefit coronary patients in Latin America and throughout the world," said Eli Bar, CTO and VP R&D of InspireMD.

Some of the unique advantages of the MGuard stent will be presented during the SOLACI congress:

- Dr. Gian Battista Danzi will discuss the "New Methods to Treat Distal Embolization with the Micro-Mesh Covered Stent" at 10:30 on Wednesday, August 11th at the Pacara Hall of the Hilton Hotel. - Dr. Cleverson Zukowski will present a case of "Residual Intra-stent thrombosis after Coronary Angioplasty in a Critical Artery of a Patient with Acute Coronary Syndrome" at 10:30 on Thursday, August 12th at the Sauce Hall of the Hilton Hotel.

Furthermore, results from the MAGICAL study and the iMOS registry will be displayed as posters

- "Six-month results of mesh covered stent implantation in ST-segment elevation myocardial infarction" - "Real-world data of the MGuard coronary stent: Early data from the iMOS Registry"

They will appear respectively at the 10:30 and 15:30 SOLACI Poster Sessions, on Thursday, August 12th, on the Hilton Hotel's second floor hall.

Also on the agenda is InspireMD's on-booth SOLACI 2010 Welcome Cocktail, to be hosted in the InspireMD booth no.17 at 19:15 on August 11th.